Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators by Yin Chan, Stephanie Pranke, Farid Rashidi, Shravan Nosib, Lawrence Worobetz

“…None of the subjects had any clinical signs of decompensated congestive heart failure or cirrhosis during the exam. Conclusion. TE with FibroScan can be safely performed in patients with PM or ICD.…”
Get full text

Effect of Intervention of Vaccination and Treatment on the Transmission Dynamics of HBV Disease: A Mathematical Model Analysis by Firaol Asfaw Wodajo, Temesgen Tibebu Mekonnen

“…Since people do not give attention, it will develop into cirrhosis and hepatocellular carcinoma that leads to liver transplantation and death. …”
Get full text

Short-Term Efficacy of Laparoscopic Treatment for Colorectal Cancer in Patients with Schistosomiasis Japonica by Zhu Yi, Jiang Hong-Gang, Chen Zhi-Heng, Lu Bo-Hao

“…Schistosomiasis is associated with numerous complications such as thrombocytopenia, liver cirrhosis, portal hypertension, and colitis. To the best of our knowledge, the feasibility and outcomes of laparoscopic colorectal surgery in patients with schistosomiasis have not yet been studied. …”
Get full text

Plasma α-Glutathione S-Transferase Evaluation in Patients with Acute and Chronic Liver Injury by Jolanta Czuczejko, Celestyna Mila-Kierzenkowska, Karolina Szewczyk-Golec

“…The patients were divided into three groups: group I (acute viral hepatitis B or C), group II (chronic hepatitis B or C), and group III (chronic liver disease or cirrhosis with different etiologies). The concentration of α-GST and the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured in all examined groups. α-GST, ALT, and AST were statistically higher in all patient groups than in the control group. …”
Get full text

Virological Mechanisms in the Coinfection between HIV and HCV by Maria Carla Liberto, Emilia Zicca, Grazia Pavia, Angela Quirino, Nadia Marascio, Carlo Torti, Alfredo Focà

“…Several studies demonstrated that HIV worsens the course of HCV infection, increasing the risk of cirrhosis and hepatocellular carcinoma. Also, HCV might increase immunological defects due to HIV and risk of comorbidities. …”
Get full text

Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters by Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, Lina Chen, Elena M. Comelli, David S. Guttman, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard

“…Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a range of histological findings from the generally benign simple steatosis to steatohepatitis (MASH) which can progress to fibrosis and cirrhosis. Several factors, including the microbiome, may contribute to disease progression. …”
Get full text

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany by Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth

“…Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of first generation protease inhibitors has significantly improved the treatment of hepatitis C genotype 1 patients. …”
Get full text

Computer-tomography features of hemodynamics in hepatocellular carcinoma foci depend on the stage of histological differentiation by U. N. Tumanova, N. I. Yashina, Ye. A. Dubova, G. G. Karmazanovsky, A. I. Schegolev

“…The study was based on the clinical and morphological data of 19 patients (12 men and 7 women, aged 18–72 years), with hepatocellular carcinoma (HCC) without coexistent liver cirrhosis. At a preoperative stage all patients underwent helical CT with bolus contrast enhancement (four phases study), with estimation of arterial and venous density gain ofthe lesion and CT-vascularization index. …”
Get full text

Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogene... by Amal Abd El Hafez, Basem H. Elesawy, Heba S. E. I. Hany

“…HCCs were statistically compared in relation with gender, age, cirrhosis, hepatitis C virus (HCV) status, alpha-fetoprotein (AFP) serum level, tumor size, multiplicity, encapsulation/invasion, grade, histological pattern and variant, mitosis, necrosis, vascular emboli, portal thrombosis, stage, recurrence, and mortality. …”
Get full text

Glycogen Storage Disease Type IX in a 6-year-old Male: A Case Report by Shahab Noorian, Hossein Moravej, Zhila Afshar, Afagh Hassanzadeh Rad, Setila Dalili

“…Ongoing research into the molecular mechanisms of GSDs offers hope for more effective treatments, especially for GSD type IX, where individualized care can prevent complications like liver cirrhosis and promote better quality of life.…”
Get full text

Pegilated interferon α2а in treatment of chronic hepatitis C by P. O. Bogomolov, S. V. Koblov, A. O. Buyeverov, M. V. Matsiyevich, O. S. Kuzmina, N. A. Barsukova, N. V. Dubinina

“…Prior to therapy onset needle liver biopsy was carried out in 88,3% of patients, subsequently liver cirrhosis was diagnosed in 77 patients. In 227 of patients the 1-st HCV genotype was revealed, 2nd genotype – in 24, 3rd genotype – in 41cases.Results. …”
Get full text

Metastatic Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review by Kyle J. Fortinsky, Ali Alali, Khursheed Jeejeebhoy, Sandra Fischer, Morris Sherman, Scott Fung

“…Hepatocellular carcinoma most commonly occurs in patients with underlying liver disease or cirrhosis. We describe a case of hepatocellular carcinoma in a 34-year-old man with Crohn’s disease treated with azathioprine and infliximab. …”
Get full text

Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma by Mei Liu, Su-jun Zheng, Yu Chen, Ning Li, Peng-fei Ren, Li-ping Dai, Zhong-ping Duan, Jian-Ying Zhang

“…The prevalence of autoantibodies against MDM2 was significantly higher than that in liver cirrhosis (LC), chronic hepatitis (CH), and normal human sera (NHS). …”
Get full text

Nuclear Imaging to Detect Diaphragmatic Perforation as a Rare Complication of Microwave Ablation by Stephanie Cull, Gebran Khneizer, Abhishek Krishna, Razi Muzaffar, Sameer Gadani, Zafar Jamkhana

“…A 57-year-old male with cirrhosis and HCC presented with respiratory distress after undergoing MWA of a HCC lesion. …”
Get full text

Feasibility and Safety of Bariatric Surgery in High-Risk Patients: A Single-Center Experience by Yusef Moulla, Orestis Lyros, Matthias Blüher, Philipp Simon, Arne Dietrich

“…., 2016) at least one of the following risk factors was met: age ≥ 70 years, body mass index (BMI) > 70 kg/m2, liver cirrhosis, end-organ failure, or immunosuppression by status after organ transplantation along with (Birkmeyer et al., 2010) at least two comorbidities associated with obesity. …”
Get full text

Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation by Edith Villeneuve, Jean Vincelette, Jean-Pierre Villeneuve

“…The response to vaccination with a recombinant HBV vaccine was examined in 49 patients with cirrhosis before liver transplantation. Patients received three doses (20 µg) of Engerix-B (SmithKline Beecham) at zero, one and two months before transplantation, and their response was measured on the day of liver transplantation (9.3±1.2 months after the initial dose of vaccine). …”
Get full text

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients by Lingjuan Ruan, Lifei Huang, Lilai Zhao, Qiang Wang, Xiaocheng Pan, Anmin Zhang, Qiuping Bai, Zongjun Lv

“…Hepatitis B virus (HBV) infection is a major risk factor for the development of hepatic cirrhosis (HC) and hepatocellular carcinoma (HCC), which are associated with very high morbidity and mortality rates worldwide. …”
Get full text

Common variable immunodeficiency: An uncommon cause of bronchiectasis, granulomatous disease, chronic liver disease, and enteropathy – Case report and review of literature by Veena Shamsudeen, Arun Hegde, Uday Bhanu Kovilapu, Nisha Verma, Anurag Jain

“…Hepatic involvement can occur in the form of abnormal biochemistry, nodular degenerative hyperplasia, and cirrhosis of liver. Treatment of infection, and replacement of immunoglobulins, remains the mainstay of management of CVID. …”
Get full text

Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C point-of-care testing. by Chrissy P B Moonen, Elfi E H G Brouwers, Christian J P A Hoebe, Nicole H T M Dukers-Muijrers, Jamila Bouchaara, Inge H M van Loo, Casper D J den Heijer

“…Undetected chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections can lead to cirrhosis and liver cancer. Syrian migrants are the largest non-European migrant group in the Netherlands with HBV and HCV prevalence rates above 2%. …”
Get full text

Chronic hepatitis C course at elderly and therapeutic approach by M. V. Mayevskaya, M. A. Morozova

“…At patients in the age of 65 and over chronic hepatitis C has more severe course, than at young patients, with more rapid progression of fibrosis and low level of alanine transaminase. Due to this liver cirrhosis (LC) at elderly patients is more frequent, than at younger subjects. …”
Get full text